MATRix is a combination of cancer drugs. It is used to treat primary CNS lymphoma. It may sometimes be used to treat other cancers. It may also be used to harvest stem cells in people …

MATRIX (Methotrexate, Cytarabine, Thiotepa and Rituximab) Version 2 Review date: May 2020 Page 2 of 5 Full dose methotrexate should only be given in the presence of a normal serum …

The MATRix (methotrexate, cytarabine, thiotepa, rituximab) regimen has significantly improved outcomes of patients with primary central nervous system lymphoma (PCNSL). The original …

Out of 156 patients treated with MATRix, 79% (n=123, 95% CI 71-85) achieved a response (35% complete response, 44% partial response), 4% (n=6) had stable disease and 10% (n=16) had …

Apr 7, 2016 · The MATRix regimen (methotrexate, cytarabine, thiotepa, rituximab) may be the new standard chemoimmunotherapy for the treatment of patients aged up to 70 years with …

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International …

MATRIX Any use of the information is subject, at all times, to CCO’s Terms and Conditions. &&2)RUPXODU\ -DQXDU\ Page 4 of 5 . EDFNWRWRS MATRIX Any use of the information …

Initiate at a rate of 20% of the total dose for the first 30 minutes and then 80% of the dose for the next 60 minutes (total infusion time of 90 minutes). If the more rapid infusion is tolerated, this …

When MATRix regimen is used for priming and harvesting: 1. Liaise with BMT nurse co-ordinator for timing of harvest and possible transplant slot. 2. Stem cell collection should be performed …

Nov 24, 2017 · MATRix (methotrexate, cytarabine, thiotepa, rituximab) This treatment cycle is repeated every 21 days. You will have up to 4 cycles. Once you have finished your …